Associated Papers
Postazacitidine clone size predicts long-term outcome of patients with myelodysplastic syndromes and related myeloid neoplasms.
Nannya Y et al.
Blood Advances, 2023
36989067 (PubMed )
Supplement: BLOODA_ADV-2022-009564-mmc2.xlsx › SuppTable2
What's different about atypical CML and chronic neutrophilic leukemia?
Dao KH et al.
Hematology. American Society of Hematology. Education Program, 2015
Significant clinical response to JAK1/2 inhibition in a patient with CSF3R-T618I-positive atypical chronic myeloid leukemia.
Dao KH et al.
Leukemia Research Reports, 2014
Select a paper to view details